2m 2m 2m 2m 2m 2m 2m
JASPER THERAPEU (JSPR)
NASDAQ
$0.51-$0.04 (-7.13%)
Price as of Jun 03, 2026 7:20 PM EDT- $23.2MMarket Cap
- -90.66%1-Year Change
- BiotechnologyIndustry
JASPER THERAPEU (JSPR)
$0.51-$0.04 (-7.13%)
JSPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.55 | ||
Change | +$0.02 (+3.20%) | ||
Open | $0.59 | ||
High | $0.61 | ||
Low | $0.43 | ||
Previous Close | $0.53 | ||
Volume | 2,852,029 | ||
30-Day Average Volume | 475,097 | ||
1-Week Change | -39.59% | ||
1-Month Change | -40.74% | ||
1-Year Change | -90.66% | ||
3-Year Change | -96.60% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 28.0M | ||
Total Assets | $21.2M | ||
Market Cap | $23.2M | ||
Enterprise Value | $9.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$14.5M | ||
EBIT | $0.00 | ||
EBITDA | $21,000.00 | ||
Net Working Capital | $11.3M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | 451 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -21 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/04/2024 | ||
Earnings & Revenue